These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10507660)

  • 1. What's the buzz (on protease inhibitors)...tell me what's (mechanistically) happening.
    Zimmerman JJ
    Crit Care Med; 1999 Sep; 27(9):2062-3. PubMed ID: 10507660
    [No Abstract]   [Full Text] [Related]  

  • 2. Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation.
    Harada N; Okajima K; Kushimoto S
    Crit Care Med; 1999 Sep; 27(9):1958-64. PubMed ID: 10507625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte protection by a protease inhibitor against ischemia/reperfusion injury of human liver.
    Kim YI; Hwang YJ; Song KE; Yun YK; Lee JW; Chun BY
    J Am Coll Surg; 2002 Jul; 195(1):41-50. PubMed ID: 12113544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats.
    Mikami K; Goto T; Miura K; Ohshima S; Yoneyama K; Lin JG; Watanabe D; Segawa D; Kataoka E; Shibuya T; Watanabe S
    J Gastroenterol; 2005 Mar; 40(3):260-5. PubMed ID: 15830285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gabexate mesilate on ischemia-reperfusion-induced testicular injury in rats.
    Gezici A; Ozturk H; Buyukbayram H; Ozturk H; Okur H
    Pediatr Surg Int; 2006 May; 22(5):435-41. PubMed ID: 16557390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a protease inhibitor in the prevention of ischemia and reperfusion injury in hepatectomy under intermittent Pringle maneuver.
    Kim YI; Chung HJ; Song KE; Hwang YJ; Lee JW; Lee YJ; Chun BY
    Am J Surg; 2006 Jan; 191(1):72-6. PubMed ID: 16399110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of synthetic protease inhibitor gabexate mesilate on the attenuation of ischemia/reperfusion injury in canine kidney autotransplantation.
    Inoue S; Sugitani A; Yamamoto H; Kitada H; Motoyama K; Okabe Y; Ohta M; Yoshida J; Nishiyama K; Tanaka M
    Surgery; 2005 Feb; 137(2):216-24. PubMed ID: 15674204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs.
    Luh SP; Tsai CC; Shau WY; Chen JS; Kuo SH; Lin-Shiau SY; Lee YC
    J Surg Res; 1999 Dec; 87(2):152-63. PubMed ID: 10600344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes.
    Murakami K; Okajima K; Uchiba M; Okabe H; Takatsuki K
    Crit Care Med; 1996 Jun; 24(6):1047-53. PubMed ID: 8681572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabexate mesilate prevents compression-induced spinal cord injury.
    Young W
    Crit Care Med; 1997 May; 25(5):725. PubMed ID: 9187587
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential cytokine response in host defence mechanisms triggered by gram-negative and gram-positive bacteria, and the roles of gabexate mesilate, a synthetic protease inhibitor.
    Iwadou H; Morimoto Y; Iwagaki H; Sinoura S; Chouda Y; Kodama M; Yoshioka T; Saito S; Yagi T; Tanaka N
    J Int Med Res; 2002; 30(2):99-108. PubMed ID: 12025532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of treating severe acute pancreatitis with gabexate is associated with neutrophil apoptosis activity.
    Chiu DF; Chen JC; Chen HM; Ng CJ; Shyr MH; Chen MF
    Hepatogastroenterology; 2003; 50(50):553-8. PubMed ID: 12749271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent.
    Camargo CA; Madden JF; Gao W; Selvan RS; Clavien PA
    Hepatology; 1997 Dec; 26(6):1513-20. PubMed ID: 9397992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabexate mesilate, a synthetic protease inhibitor, prevents compression-induced spinal cord injury by inhibiting activation of leukocytes in rats.
    Taoka Y; Okajima K; Uchiba M; Murakami K; Kushimoto S; Johno M; Naruo M; Okabe H; Takatsuki K
    Crit Care Med; 1997 May; 25(5):874-9. PubMed ID: 9187610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of gabexate mesilate on the microsurgical reconstruction of the hepatic artery in living donor liver transplantation.
    Miyagi S; Enomoto Y; Sekiguchi S; Kawagishi N; Satomi S
    Transplant Proc; 2010 Dec; 42(10):4158-60. PubMed ID: 21168651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitors for prevention of ERCP pancreatitis: can we afford the price of success?
    Ziebert JJ; Bjorkman DJ
    Am J Gastroenterol; 1997 Jun; 92(6):1067-8. PubMed ID: 9177543
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of DIC with a serine proteinase inhibitor.
    Yokota T; Yamada Y; Takahashi M; Kunii Y; Iwamoto K; Kagami M; Kikuchi S; Yamauchi H; Yoshikawa K
    Am J Emerg Med; 2001 Jul; 19(4):334-5. PubMed ID: 11447540
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylaxis of post-ERCP pancreatic complications with gabexate.
    Piscaglia F; Righini R; Tewelde AG
    Dig Liver Dis; 2007 Mar; 39(3):291; author reply 291. PubMed ID: 17267312
    [No Abstract]   [Full Text] [Related]  

  • 19. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography.
    Schneider J; Barkin J
    Gastrointest Endosc; 1997 May; 45(5):447-8. PubMed ID: 9165340
    [No Abstract]   [Full Text] [Related]  

  • 20. The antifibrotic effect of a serine protease inhibitor in the kidney.
    Morinaga J; Kakizoe Y; Miyoshi T; Onoue T; Ueda M; Mizumoto T; Yamazoe R; Uchimura K; Hayata M; Shiraishi N; Adachi M; Sakai Y; Tomita K; Kitamura K
    Am J Physiol Renal Physiol; 2013 Jul; 305(2):F173-81. PubMed ID: 23698112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.